Becton, Dickinson and Company (BDX)

業務介紹

貝克頓、狄金森及公司開發、製造和銷售醫療用品、設備、實驗室設備和診斷產品,供全球醫療機構、醫生、生命科學研究人員、臨床實驗室、製藥業和大眾使用。

該公司的BD醫療部門提供外周靜脈(IV)和先進的外周導管、中心靜脈導管、急性透析導管、血管護理和準備產品、無針IV連接器和延長管、密閉式藥物轉移設備、有害藥物檢測、注射器和針頭、麻醉針和托盤、腸內注射器和尖銳物品處理系統;IV藥物和輸液療法輸送系統、藥物配藥工作流程系統、自動化藥物配發和供應管理系統,以及藥物庫存優化和跟蹤系統;用於糖尿病的注射器、筆針和其他產品;以及預填充式藥物遞送系統。

其BD生命科學部門提供標本和採血產品;自動血液和結核病培養、分子檢測、微生物鑑定和藥物敏感性,以及液基細胞學系統,以及快速診斷試劑、微生物實驗室自動化產品和培養基產品;以及細胞分選和分析儀、抗體和試劑盒、試劑系統,以及用於單細胞基因表達分析的解決方案,以及臨床腫瘤學、免疫學和移植診斷/監測試劑和分析儀。

該公司的BD介入部門提供疝氣和軟組織修復、生物和可吸收移植物、生物外科手術和其他外科產品;手術感染預防、外科和腹腔鏡手術器械產品;外周介入產品;以及泌尿科和危重監護產品。

該公司成立於1897年,總部位於新澤西州富蘭克林湖。



Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

公司網址

https://www.bd.com